DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Pricing, Market Access, and Reimbursement Strategy

Formerly known as PharmaStrat, our focus on pricing, market access, and reimbursement strategy provides our clients with exceptional decision-making resources.  In an ever-evolving, increasingly competitive commercial landscape, achieving optimal market access is becoming ever more challenging for pharmaceutical clients. In the wake of the global economic crisis, escalating costs and declining healthcare budgets mean that payers, both national and local, have a substantial and growing influence on a product's commercial success.

A completely customized service, tailored to meet your needs

Solving Global Payer Landscape Challenges

 

Our Payer Strategy team are experts in understanding the global payer landscape and can help you overcome the evolving market access challenges. We work with you to identify and engage key stakeholders, survey the reimbursement landscape and generate value insights & messaging to help shape your market access strategy at any stage throughout your product’s lifecycle.

 

Key services include:

  • Payer landscaping and competitive intelligence (incl. HTAInSite – a subscription service that helps you understand what drives HTA decision making for your product area in the United Kingdom)
  • Payer and KOL engagement
  • Value message development and testing
  • Market access strategy development
  • TPP development and testing
  • Stakeholder mapping
  • Stakeholder mapping
  • Pricing research
  • Advisory boards
  • Payer segmentation
  • Policy and publication support
  • Negotiation strategy
  • Patient Access Scheme testing & innovative contracting

Whether you want to understand how to avoid the access and price restrictions competitor products have been given, or need a holistic understanding of a disease area and payer requirements in key markets, our team can support you.

Payer Decision & Evidence Platforms

 

Our fully customized Payer Decision & Evidence Platforms offer you payer intelligence generated using our integrated in-house market knowledge, global language expertise and market-leading web solutions. We tailor each database solution to your research priorities to give you the insight required to inform your assets’ global market access strategies.

 

Searchable
House global payer intelligence, analyzed according to your key criteria and accessible through power-search and filter functionalities.Simple to Use
Provide a source of visually appealing dashboards consisting of charts and graphs displaying cross-market decision trends and HTA requirements, all of which can be easily exported to your custom reports and presentations.
Centralized
Rationalize your own payer research and custom reports by providing a single, interactive repository for all affiliates and global teams.Automated
Provide regular automated email updates on HTA developments in markets or therapeutic areas of your choice.